S Gail Eckhardt Selected Research

S Gail Eckhardt Research Topics

Disease

121	Neoplasms (Cancer) 01/2022 - 01/2002
29	Colorectal Neoplasms (Colorectal Cancer) 10/2019 - 07/2006
11	Melanoma (Melanoma, Malignant) 01/2021 - 07/2002
9	Triple Negative Breast Neoplasms 11/2020 - 01/2013
6	Neutropenia 04/2016 - 11/2004
6	Nausea 08/2013 - 07/2002
6	Colonic Neoplasms (Colon Cancer) 01/2013 - 07/2006
5	Fatigue 01/2022 - 07/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 04/2016 - 09/2006
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016 - 11/2004
5	Breast Neoplasms (Breast Cancer) 05/2014 - 05/2006
5	Thrombocytopenia (Thrombopenia) 09/2009 - 09/2006
4	Adenocarcinoma 01/2021 - 09/2006
4	Diarrhea 08/2013 - 07/2002
4	Vomiting 04/2011 - 07/2002
4	Lung Neoplasms (Lung Cancer) 10/2010 - 02/2002
3	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 02/2011
3	Adenocarcinoma of Lung 01/2019 - 08/2006
3	Exanthema (Rash) 01/2018 - 11/2007
3	Disease Progression 05/2013 - 10/2004
3	Fever (Fevers) 09/2009 - 07/2002
3	Carcinoma (Carcinomatosis) 09/2009 - 08/2005
2	Pain (Aches) 01/2022 - 02/2009
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 05/2012
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 08/2005
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2020 - 09/2009
2	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2016
2	Hypertension (High Blood Pressure) 01/2018 - 02/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 03/2007

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 11/2021 - 07/2002
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2006
15	Phosphotransferases (Kinase)IBA 12/2018 - 07/2006
11	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018 - 11/2006
9	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 08/2007
8	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2008
7	Biological ProductsIBA 02/2020 - 10/2003
7	AZD 6244IBA 01/2018 - 05/2008
7	Monoclonal AntibodiesIBA 01/2018 - 08/2006
7	ErbB Receptors (EGF Receptor)IBA 10/2010 - 08/2006
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 08/2006
6	Tyrosine Kinase InhibitorsIBA 04/2016 - 11/2007
6	LigandsIBA 03/2015 - 07/2008
6	Docetaxel (Taxotere)FDA Link 03/2010 - 08/2003
5	Capecitabine (Xeloda)FDA Link 01/2021 - 08/2007
5	Gemcitabine FDA Link 04/2016 - 10/2003
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 10/2005
4	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 10/2005
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
4	PlatinumIBA 11/2020 - 02/2002
4	Aurora Kinase AIBA 01/2020 - 06/2010
4	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 12/2018 - 11/2010
4	EnzymesIBA 01/2018 - 07/2002
4	ENMD 2076IBA 01/2017 - 06/2010
4	vandetanib (ZD6474)IBA 04/2016 - 07/2006
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2016 - 11/2007
4	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 10/2004
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016 - 09/2008
4	Imatinib Mesylate (Gleevec)FDA Link 02/2013 - 10/2004
4	Cetuximab (Erbitux)FDA Link 10/2010 - 08/2006
4	Tyrosine (L-Tyrosine)FDA Link 06/2010 - 07/2006
3	Histone Deacetylase InhibitorsIBA 01/2022 - 07/2008
3	CateninsIBA 11/2020 - 03/2014
3	AntigensIBA 10/2020 - 01/2017
3	MLN 8237IBA 01/2020 - 05/2015
3	CreatinineIBA 01/2018 - 08/2002
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 07/2006
3	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2017 - 12/2008
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 11/2010 - 04/2010
3	Bortezomib (Velcade)FDA Link 10/2010 - 02/2009
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2010 - 08/2006
3	phosphomannopentaose sulfateIBA 03/2010 - 09/2006
3	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 02/2010 - 10/2005
3	Gefitinib (Iressa)FDA Link 04/2009 - 11/2007
2	adavosertibIBA 01/2021 - 03/2020
2	RX-5902IBA 11/2020 - 11/2019
2	Bevacizumab (Avastin)FDA Link 11/2020 - 05/2006
2	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 05/2006
2	c-Mer Tyrosine KinaseIBA 01/2019 - 05/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 05/2013
2	Insulin ReceptorIBA 12/2018 - 11/2013
2	Immunoglobulin G (IgG)IBA 01/2018 - 02/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2018 - 08/2013
2	Protein Kinases (Protein Kinase)IBA 01/2017 - 05/2014
2	Mitogen-Activated Protein KinasesIBA 01/2017 - 10/2010
2	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 10/2010
2	Epidermal Growth Factor (EGF)IBA 04/2016 - 08/2013
2	TAK 733IBA 10/2015 - 02/2015
2	Polo-Like Kinase 1IBA 03/2014 - 04/2012
2	ON 01910IBA 03/2014 - 04/2012
2	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2014 - 05/2012
2	Small Interfering RNA (siRNA)IBA 08/2013 - 05/2013
2	AgarIBA 05/2013 - 10/2010
2	PF 3758309IBA 01/2013 - 01/2013
2	Aurora KinasesIBA 01/2013 - 02/2011

Therapy/Procedure

38	Therapeutics 01/2022 - 02/2002
12	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
7	Immunotherapy 01/2021 - 01/2016
3	Radiotherapy 10/2010 - 10/2008
2	Aftercare (After-Treatment) 01/2017 - 07/2003
2	Drug Tapering 08/2013 - 08/2002